Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.

Yuga KomakiFukiko KomakiDejan MicicAkihiro YamadaYasuo SuzukiAtsushi Sakuraba

Published in: Journal of gastroenterology and hepatology (2017)

The results of the present comprehensive benefit-risk assessment using network meta-analysis provide RCT-based evidence on efficacy and safety of infliximab, cyclosporine, and tacrolimus for hospitalized patients with severe steroid refractory UC.

Keyphrases

ulcerative colitis
risk assessment
systematic review
early onset
meta analyses
heavy metals
human health
case control
climate change